Balance Sheet Data

Gilead Sciences, Inc. (GILD)

$78.05

-1.31 (-1.65%)

Year
A/P
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Projected
2024
Projected
2025
Projected
2026
Projected
2027
Projected
Total Cash 31,51225,8407,9107,8297,63019,925.4421,018.4122,171.3423,387.5124,670.40
Total Cash (%)
Account Receivables 3,3273,5824,8924,4934,7774,879.035,146.665,428.985,726.776,040.91
Account Receivables (%)
Inventories 8142,0673,0142,7342,8202,615.522,758.992,910.333,069.973,238.36
Inventories (%)
Accounts Payable 790713844705905924.57975.291,028.791,085.221,144.75
Accounts Payable (%)
Capital Expenditure -924-825-650-579-728-879.02-927.23-978.09-1,031.75-1,088.34
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.